media – Page 614 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Merck sales slip, even as Keytruda gains ground

Keytruda (pembrolizumab) was the main bright spot for Merck as it weathered blows from the NotPetya cyber attack, new competition and pricing pressures in hepatitis C.
- Source: 4-traders
- 692
- October 31, 2017
hepatitis inhibitor keytruda Market Views Opdivo
Novartis Slams Down $3.9B for This French Cancer Biotech

Fresh off the heels of its CAR-T approval, Novartis expanded its oncological arsenal with a $3.9 billion acquisition of French cancer firm Advanced Accelerator Applications.
- Source: Biospace
- 802
- October 31, 2017
CAR–T GEP-NETs Market Views neuroendocrine tumors
WHO report signals urgent need for greater political commitment to end tuberculosis

Global efforts to combat tuberculosis (TB) have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37%, according to the Global TB Report 2017, released by WHO today.
- Source: who
- 598
- October 31, 2017
Market Views tuberculosis WHO
PTSD linked to changes in gut bacteria

An exploratory study has identified a link between gut bacteria and post-traumatic stress disorder that could bring us closer to fathoming the mechanisms of the complex condition.
- Source: medicalnewstoday
- 709
- October 31, 2017
gut bacteria post-traumatic PTSD Researches
CVS-Aetna deal won’t necessarily make drugs cheaper — and could even raise prices

CVS Health Corp.’s bid for Aetna Inc., which could be valued at more than $66 billion, would — if successful — combine two businesses that have traditionally been separate, health insurance and pharmacy-benefit management.
- Source: marketwatch
- 432
- October 31, 2017
Company Insight CVS drug pharmacy
Ddu Attended CPhI Worldwide in Germany, Gaining Attention from the Whole Industry

The International Pharmaceutical Networking Exhibition (CPhI Worldwide 2017), was held at Ludwig-Erhard-Anlage 1 in Messe, Frankfurt, Germany from the 24th to the 26th of October 2017. As the leading global pharmaceutical & medical device B2B online platform, Ddu attended the exhibition, gaining attention from the whole industry.
- Source: Ddu
- 1,597
- October 31, 2017
CPhI Worldwide 2017 Exhibitions & Activities
FDA Calls BioMarin’s Hemophilia A Drug a Breakthrough

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation.
- Source: biospace
- 806
- October 31, 2017
Clinical Trial FDA hemophilia A
How flu shot manufacturing forces influenza to mutate

According to a new study from scientists at The Scripps Research Institute (TSRI), the common practice of growing influenza vaccine components in chicken eggs disrupts the major antibody target site on the virus surface, rendering the flu vaccine less effective in humans.
- Source: Medicalxpress
- 855
- October 31, 2017
antibody influenza vaccine
CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

Prospects for GlaxoSmithKline’s new shingle vaccine Shingrix have been raised after US advisors recommended that it should be used instead of rival Zostavax from Merck & Co.
- Source: Pmlive
- 924
- October 30, 2017
Company Insight HIV Shingrix Tivicay Triumeq vaccine
Pfizer to launch consumer health sale in November

Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.
- Source: Pharmacodia
- 624
- October 30, 2017
Consumer Healthcare Market Views pill

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.